These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2527299)

  • 1. Effect of a novel 5-hydroxytryptamine3-antagonist, GR38032F, on the 5-hydroxytryptamine-induced increase in carotid sinus nerve activity in rats.
    Yoshioka M
    J Pharmacol Exp Ther; 1989 Aug; 250(2):637-41. PubMed ID: 2527299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 5-hydroxytryptamine on external carotid nerve activity and its blockade by GR38032F in anesthetized rats.
    Yoshioka M; Ikeda T; Abe M; Togashi H; Saito H
    Res Commun Chem Pathol Pharmacol; 1991 Oct; 74(1):39-45. PubMed ID: 1839326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat.
    Yoshioka M; Goda Y; Togashi H; Matsumoto M; Saito H
    J Pharmacol Exp Ther; 1992 Feb; 260(2):917-24. PubMed ID: 1531363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 5-hydroxytryptamine on gastric motility and efferent gastric vagus nerve activity in rats.
    Yoshioka M; Ikeda T; Togashi H; Saito Y; Saito H
    Res Commun Chem Pathol Pharmacol; 1990 Oct; 70(1):3-10. PubMed ID: 2263761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ventilatory mechanical analysis of respiratory depression induced by serotonin].
    Goda Y
    Hokkaido Igaku Zasshi; 1993 Jan; 68(1):29-41. PubMed ID: 8444402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.
    Butler A; Hill JM; Ireland SJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1988 Jun; 94(2):397-412. PubMed ID: 2969267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT activates vagal afferent cell bodies in vivo: role of 5-HT2 and 5-HT3 receptors.
    Lacolley P; Owen JR; Sandock K; Lewis TH; Bates JN; Robertson TP; Lewis SJ
    Neuroscience; 2006 Nov; 143(1):273-87. PubMed ID: 17029799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum.
    Blandina P; Goldfarb J; Craddock-Royal B; Green JP
    J Pharmacol Exp Ther; 1989 Dec; 251(3):803-9. PubMed ID: 2600815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of 5-hydroxytryptamine-induced excitation of afferent cervical vagus nerve in anaesthetized rats.
    Yoshioka M; Ikeda T; Abe M; Togashi H; Minami M; Saito H
    Br J Pharmacol; 1992 Jul; 106(3):544-9. PubMed ID: 1387026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule.
    Marek GJ; Seiden LS
    J Pharmacol Exp Ther; 1988 Feb; 244(2):650-8. PubMed ID: 2894458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of YM060, a potent and selective 5-hydroxytryptamine3 receptor antagonist, in rabbit nodose ganglion and N1E-115 neuroblastoma cells.
    Ito H; Hidaka K; Miyata K; Kamato T; Nishida A; Honda K
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1127-32. PubMed ID: 1469624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury.
    Oatway MA; Chen Y; Weaver LC
    Pain; 2004 Jul; 110(1-2):259-68. PubMed ID: 15275776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat.
    Morán A; Ortiz de Urbina AV; Martín ML; García M; Rodriguez-Barbero A; Dorado F; San Román L
    Eur J Pharmacol; 2008 Sep; 592(1-3):133-7. PubMed ID: 18644367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 5-hydroxytryptamine on the peripheral chemoreceptors in the rat.
    Sapru HN; Krieger AJ
    Res Commun Chem Pathol Pharmacol; 1977 Feb; 16(2):245-50. PubMed ID: 847283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
    Lucki I; Nobler MS; Frazer A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.
    Kadowaki M; Nagakura Y; Tomoi M; Mori J; Kohsaka M
    J Pharmacol Exp Ther; 1993 Jul; 266(1):74-80. PubMed ID: 8331576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of GK-128 [2-[(2-methylimidazol-1-yl)methyl]-benzo[f]thiochromen-1-one monohydrochloride hemihydrate], a selective 5-hydroxytryptamine3 receptor antagonist, on colonic function in rats.
    Ito C; Isobe Y; Kawamura R; Kiuchi Y; Tsuchida K; Higuchi S
    J Pharmacol Exp Ther; 1997 Jan; 280(1):67-72. PubMed ID: 8996183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a 5-HT4 receptor pathway mediating chloride secretion in the rat distal colon.
    Budhoo MR; Kellum JM
    J Surg Res; 1994 Jul; 57(1):44-8. PubMed ID: 8041147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist.
    Nagakura Y; Kadowaki M; Tokoro K; Tomoi M; Mori J; Kohsaka M
    J Pharmacol Exp Ther; 1993 May; 265(2):752-8. PubMed ID: 8496821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.